BioCentury's June 5 roundup includes UCB's acquisition of Engage; plus news from Merck, Tetraphase, Apeiron, Neurasic, Jounce and J&amp;J $UCB $MRK $TTPH $MLNTQ $JNCE $BMY $GMAB https://t.co/hMc9aX6dc5